Cargando…

“Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry

Coronavirus Disease 2019 (COVID-19) remains a global health crisis, despite the development and success of vaccines in certain countries. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, uses its spike protein to bind to the human cell surface receptor an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shukla, Satya Prakash, Cho, Kwang Bog, Rustagi, Vineeta, Gao, Xiang, Fu, Xinping, Zhang, Shaun Xiaoliu, Guo, Bin, Udugamasooriya, D. Gomika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396575/ https://www.ncbi.nlm.nih.gov/pubmed/34445669 http://dx.doi.org/10.3390/ijms22168963

Ejemplares similares

A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in mice
por: Cho, Kwang Bog, et al.
Publicado: (2022)

Development of a large peptoid–DOTA combinatorial library
por: Singh, Jaspal, et al.
Publicado: (2016)

Potent and Selective Photo-inactivation of Proteins With Peptoid-Ruthenium Conjugates
por: Lee, Jiyong, et al.
Publicado: (2010)

Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells
por: Raymond, Aaron C., et al.
Publicado: (2019)

GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
por: Lynn, Kristi D, et al.
Publicado: (2010)

Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1
por: Desai, Tanvi J., et al.
Publicado: (2016)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
por: Hoffmann, Markus, et al.
Publicado: (2020)

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
por: Djomkam, Alexandra Lindsey Zune, et al.
Publicado: (2020)

Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor
por: Kim, Young Soo, et al.
Publicado: (2021)

Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
por: Roland, Christina L., et al.
Publicado: (2009)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction
por: Mahindra, Amit, et al.
Publicado: (2021)

The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry
por: Zhang, Junsong, et al.
Publicado: (2021)

Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants
por: Li, Minchao, et al.
Publicado: (2022)

Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system
por: Li, Mingzhe, et al.
Publicado: (2020)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
por: He, Ming-Feng, et al.
Publicado: (2022)

Abstract 1390: Multiplex measurements of the impacts of ACE2 sequence and cell surface abundance during SARS-like coronavirus entry
por: Shukla, Nidhi, et al.
Publicado: (2023)

Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
por: Wang, Peiyu, et al.
Publicado: (2022)

ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells
por: Guo, Hua, et al.
Publicado: (2022)

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020)

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
por: Wang, Qihui, et al.
Publicado: (2020)

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
por: Ahmad, Iqrar, et al.
Publicado: (2021)

TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
por: Wang, Yinfang, et al.
Publicado: (2021)

Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
por: D’Onofrio, Nunzia, et al.
Publicado: (2021)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
por: Karthika, Thankamani, et al.
Publicado: (2021)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium
por: Jacobs, Merel, et al.
Publicado: (2021)

Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
por: Liu, Yichuan, et al.
Publicado: (2020)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor
por: Fonnesu, Rossella, et al.
Publicado: (2022)

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells
por: Zhang, Liqun, et al.
Publicado: (2021)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
por: Fu, Xinping, et al.
Publicado: (2020)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2
por: Struck, Anna-Winona, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kden8pin051uur2fmlkrsljne2